Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2025-12-25 @ 5:31 PM
NCT ID: NCT04281004
Description: All deaths, Serious Adverse Events, and other ocular Adverse Events regardless of seriousness were reported.
Frequency Threshold: 0
Time Frame: Randomization through last study visit (12 months after the last study dose), up to 56 weeks.
Study: NCT04281004
Study Brief: Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Amniotic Fluid (AFED) Amniotic Fluid (AFED): One drop (0.25 mL) of Amniotic Fluid Eye Drops (AFED) in each eye four times daily for seven days 0 None 0 28 2 28 View
Saline Solution Saline Solution: One drop (0.25 mL) of Saline Solution in each eye four times daily for seven days 0 None 0 32 1 32 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Intraocular pressure increased SYSTEMATIC_ASSESSMENT Investigations MedDRA (26.1) View
Syncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (26.1) View